tiprankstipranks
Trending News
More News >
JEOL Ltd. (JP:6951)
:6951
Japanese Market
Advertisement

JEOL Ltd. (6951) AI Stock Analysis

Compare
4 Followers

Top Page

JP:6951

JEOL Ltd.

(6951)

Select Model
Select Model
Select Model
Neutral 65 (OpenAI - 4o)
Rating:65Neutral
Price Target:
¥5,017.00
▲(5.20% Upside)
JEOL Ltd.'s overall stock score is driven by strong financial performance and reasonable valuation. However, bearish technical indicators weigh down the score, suggesting caution in the short term. The absence of earnings call data and corporate events limits additional insights.
Positive Factors
Cash Flow Management
The significant growth in Free Cash Flow enhances JEOL's financial flexibility, allowing it to fund operations and investments internally, which is crucial for sustainable growth.
Balance Sheet Health
A strong equity ratio and low debt-to-equity ratio indicate a well-capitalized balance sheet, providing JEOL with stability and the ability to weather economic fluctuations.
Revenue Growth
Consistent revenue growth reflects JEOL's successful market penetration and product demand, supporting long-term business expansion and competitive positioning.
Negative Factors
Profit Margin Pressure
The decline in net profit margin suggests rising costs or competitive pressures, which could impact profitability if not addressed, affecting shareholder returns.
Return on Equity Decline
A declining ROE indicates that profitability growth is not keeping pace with equity growth, potentially reducing attractiveness to investors seeking efficient capital use.
Revenue Growth Challenges
Negative revenue growth in recent data may signal market saturation or increased competition, posing a challenge to sustaining long-term growth momentum.

JEOL Ltd. (6951) vs. iShares MSCI Japan ETF (EWJ)

JEOL Ltd. Business Overview & Revenue Model

Company DescriptionJEOL Ltd. engages in the research, development, manufacture, and marketing of scientific and metrology instruments, semiconductor and industrial equipment, and medical equipment. The company provides transmission electron microscopes; scanning electron microscopes; ion beam application equipment, including specimen preparation equipment and multibeam systems; instruments for micro area and surface analysis, such as electron probe micro analyzers, auger microprobes, and photoelectron spectrometers; magnetic resonance equipment, such as nuclear magnetic resonance and electron spin resonance spectrometers; X-ray fluorescence spectrometers; mass spectrometers; electron beam lithography systems; and clinical chemistry analyzers. It also offers industrial equipment for thin-film formation and material processing, including thin film formation equipment and material processing equipment. The company was formerly known as Japan Electron Optics Laboratory Co., Ltd. and changed its name to JEOL Ltd. in 1961. JEOL Ltd. was founded in 1949 and is headquartered in Akishima, Japan.
How the Company Makes MoneyJEOL Ltd. generates revenue primarily through the sale of its high-precision instruments and systems, including electron microscopes, mass spectrometers, and other analytical equipment. The company also earns income through maintenance and support services for its products, which ensures ongoing customer engagement. Additionally, JEOL has established partnerships with research institutions and universities, enhancing its market presence and driving sales through collaborative projects and research initiatives. As a result, the company benefits from both direct sales and long-term service contracts, contributing to a stable revenue stream.

JEOL Ltd. Financial Statement Overview

Summary
JEOL Ltd. displays strong financial performance with robust revenue growth and effective cash flow management. The company maintains a well-capitalized balance sheet with a conservative leverage profile. However, slight pressures on profitability margins, such as the decrease in Net Profit Margin and ROE, suggest areas for improvement.
Income Statement
85
Very Positive
JEOL Ltd. exhibits strong revenue growth with a consistent upward trajectory in Total Revenue over the past years, achieving a notable revenue growth rate of 12.8% from 2024 to 2025. The Gross Profit Margin remains healthy at around 47% in 2025, indicating efficient cost management. However, the Net Profit Margin slightly decreased from 12.5% in 2024 to 9.5% in 2025, which could suggest increased expenses or competitive pressures. The company maintains robust EBIT and EBITDA margins, reflecting solid operating performance.
Balance Sheet
78
Positive
JEOL Ltd. demonstrates financial stability with a strong Equity Ratio of 61.4% in 2025, indicating a well-capitalized balance sheet. The Debt-to-Equity ratio is low at 0.07, showcasing a conservative leverage position. However, Return on Equity (ROE) decreased from 17.3% in 2024 to 13.7% in 2025, suggesting that profitability growth is not keeping pace with equity growth, potentially impacting shareholder returns.
Cash Flow
80
Positive
The company shows impressive Free Cash Flow growth, increasing from ¥11.8 billion in 2024 to ¥20.1 billion in 2025, which enhances financial flexibility. The Operating Cash Flow to Net Income ratio is strong, indicating efficient cash generation relative to net earnings. The Free Cash Flow to Net Income ratio also improved, showcasing effective cash management and a healthy ability to fund operations and investments internally.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue200.49B196.69B174.34B162.69B138.41B110.44B
Gross Profit93.61B92.40B79.28B72.70B55.37B42.89B
EBITDA32.13B30.26B34.31B28.71B18.48B9.44B
Net Income19.46B18.69B21.70B17.83B12.28B3.75B
Balance Sheet
Total Assets220.17B222.49B230.21B199.28B189.56B146.39B
Cash, Cash Equivalents and Short-Term Investments40.76B36.14B31.50B34.25B44.23B15.38B
Total Debt6.17B9.28B15.78B12.48B17.11B33.34B
Total Liabilities82.70B85.83B104.70B97.39B103.66B95.39B
Stockholders Equity137.47B136.65B125.51B101.89B85.90B51.00B
Cash Flow
Free Cash Flow0.0020.14B11.83B-3.04B21.09B-3.67B
Operating Cash Flow0.0023.10B15.30B3.35B22.60B3.36B
Investing Cash Flow0.00-855.00M-18.03B-5.73B-648.00M-6.99B
Financing Cash Flow0.00-17.12B-798.00M-8.73B5.52B3.29B

JEOL Ltd. Technical Analysis

Technical Analysis Sentiment
Negative
Last Price4769.00
Price Trends
50DMA
5044.31
Negative
100DMA
4747.76
Positive
200DMA
4648.61
Positive
Market Momentum
MACD
-125.38
Positive
RSI
43.36
Neutral
STOCH
30.35
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:6951, the sentiment is Negative. The current price of 4769 is below the 20-day moving average (MA) of 4967.30, below the 50-day MA of 5044.31, and above the 200-day MA of 4648.61, indicating a neutral trend. The MACD of -125.38 indicates Positive momentum. The RSI at 43.36 is Neutral, neither overbought nor oversold. The STOCH value of 30.35 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:6951.

JEOL Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
77
Outperform
$575.89B15.2711.99%0.74%8.50%14.06%
75
Outperform
$1.23T23.5810.84%1.56%3.92%9.99%
74
Outperform
$553.22B37.954.19%2.49%3.97%-41.79%
72
Outperform
$698.52B23.178.09%2.37%11.18%-0.75%
70
Outperform
$720.96B25.8214.01%1.11%19.45%41.03%
65
Neutral
¥266.99B13.751.96%-0.69%-29.88%
61
Neutral
$37.18B12.37-10.20%1.83%8.50%-7.62%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:6951
JEOL Ltd.
4,769.00
-437.54
-8.40%
JP:6965
Hamamatsu Photonics KK
1,555.50
-161.86
-9.42%
JP:6856
Horiba
14,220.00
6,120.51
75.57%
JP:6806
HIROSE ELECTRIC CO
17,945.00
115.95
0.65%
JP:7701
Shimadzu
4,464.00
282.48
6.76%
JP:4186
Tokyo Ohka Kogyo Co
5,777.00
2,344.12
68.28%

JEOL Ltd. Corporate Events

JEOL Ltd. Announces Disposal of Treasury Shares for Executive Compensation
Nov 14, 2025

JEOL Ltd. has announced a resolution to dispose of 120,000 treasury shares as part of a stock compensation plan for its directors and executives. This move is aligned with the company’s strategy to enhance the performance-linked stock compensation system, which aims to improve the company’s medium- to long-term performance and corporate value. The disposal is expected to have minimal impact on the stock market due to the controlled release of shares.

The most recent analyst rating on (JP:6951) stock is a Buy with a Yen6300.00 price target. To see the full list of analyst forecasts on JEOL Ltd. stock, see the JP:6951 Stock Forecast page.

JEOL Ltd. Enhances Stock Compensation System with Additional Investment
Nov 14, 2025

JEOL Ltd. announced an additional contribution to its performance-linked stock compensation system, initially introduced in 2018. This move, involving a 1,450 million yen investment, aims to continue incentivizing eligible directors and officers by acquiring company shares, thereby aligning their interests with corporate performance and enhancing stakeholder value.

The most recent analyst rating on (JP:6951) stock is a Buy with a Yen6300.00 price target. To see the full list of analyst forecasts on JEOL Ltd. stock, see the JP:6951 Stock Forecast page.

JEOL Ltd. Reports Decline in Semi-Annual Financial Performance Amid Market Challenges
Nov 14, 2025

JEOL Ltd. reported a decline in its financial performance for the six months ending September 30, 2025, with net sales and profits showing a year-on-year decrease. Despite the downturn, the company maintained a strong equity-to-asset ratio, indicating financial stability. The announcement highlights challenges in the market environment but also underscores JEOL’s commitment to sustaining its market position through strategic planning and financial management.

The most recent analyst rating on (JP:6951) stock is a Buy with a Yen6300.00 price target. To see the full list of analyst forecasts on JEOL Ltd. stock, see the JP:6951 Stock Forecast page.

JEOL Ltd. Transfers Medical Equipment Business to Sysmex for Strategic Growth
Sep 2, 2025

JEOL Ltd. has announced a strategic move to transfer its medical equipment business to a newly established subsidiary, which will then be acquired by Sysmex Corporation. This decision aims to leverage Sysmex’s strong industry presence and resources to drive sustainable growth and enhance JEOL’s corporate value through synergies in research, development, and business expansion.

The most recent analyst rating on (JP:6951) stock is a Buy with a Yen5332.00 price target. To see the full list of analyst forecasts on JEOL Ltd. stock, see the JP:6951 Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 18, 2025